FDA guidance on Essure birth control expected in February

By Sabriya Rice  |  November 24, 2015

The U.S. Food and Drug Administration expects to release new guidance by the end of February on a form of birth control that has been linked to more than 15,000 adverse events, including at least a dozen deaths.

Researchers defend 'unethical' med-student work-hour study

By Sabriya Rice  |  November 20, 2015

While there are passionate opinions on how many hours medical residents should work per shift, there is very little data to suggest that slashing their schedules is ultimately safest for the patient, researchers say. The shorter hours could also result in unintended consequences, argue supporters...

Blog: California cancer surgeries often done at low-volume facilities

By Sabriya Rice  |  November 20, 2015

Despite evidence of the correlation between low volumes and worse patient outcomes, more than 600 cancer surgeries in California were performed at hospitals that did only one or two of the procedures a calendar year, according to a report released Thursday.

Studies on resident work hours 'highly unethical,' lack patient consent

By Sabriya Rice  |  November 19, 2015

Two studies that randomly assigned first-year medical interns to work longer hours than recommended to see the impact on patient outcomes are "highly unethical," said Public Citizen and the American Medical Student Association in letters sent Tuesday to HHS.

Joint Commission shelves Top Performer program

Joint Commission shelves Top Performer program

By Sabriya Rice  |  November 17, 2015

In the current chaotic state of healthcare quality measures, the Joint Commission is suspending its highly popular Top Performer award for at least a year. It's still putting out this year's list, and a total of 1,043 hospitals made the cut. That's about 180 fewer high achievers than last year.

CMS won't step in to provide stricter oversight of laboratory-developed tests

By Virgil Dickson  |  November 17, 2015

Providers say they don't have the resources to adhere to enforcement of decades-old laws calling for the FDA to police laboratory-developed tests. The CMS rejected requests that it, not the FDA, have oversight of the tests, which are manufactured and performed within a single hospital or in...

FDA nominee Califf questioned on drug costs in confirmation hearing

FDA nominee Califf questioned on drug costs in confirmation hearing

By Shannon Muchmore  |  November 17, 2015

Dr. Robert Califf's nomination to head the Food and Drug Administration appeared poised to move forward after his Senate confirmation hearing in spite of pointed questions on drug costs and his connections to pharmaceutical companies.

Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.